PONS

PONS creates disease progression insights that were never collected before.

PONS is a business in healthcare based in Newark New Jersey, founded in 2023.

Profile

PONS is disrupting the $100B clinical trial and biomarker industry by converting any mobile ultrasound into a powerful data source. Currently the healthcare system is limited by some major blind spots: 90% of clinical drug development fails, and we fail to collect high-quality, large-scale data on early-stage disease. PONS is solving this problem by converting any mobile ultrasound with AI into a powerful high-quality data source. PONS takes point-of-care ultrasound beyond imaging and turns it into a data engine. This ensures that capturing of data on healthy samples, as well as those in early- and later-stage disease can be captured and utilized. Imagine pharmacies and retail stores becoming mini-imaging hubs. Using PONS’s AI-powered pods, rich data can be gathered that fuels drug development, personalized medicine and accelerates the timeline for life-saving treatments.

As a business in healthcare, PONS is listed here with the public details available about it.

Its base of operations is Newark New Jersey.

The company is listed at the SOSV portfolio company stage of development.

Its team size is recorded as 2-10 employees.

Public records show total funding of about $1.8M.

Website: ponstech.co